Everolimus for cardiac rhabdomyomas in children with tuberous sclerosis. the ORACLE study protocol (everOlimus for caRdiac rhAbdomyomas in tuberous sCLErosis): A randomised, multicentre, placebo-controlled, double-blind phase II trial
Academic Article in Scopus
- Overview
- Identity
- Additional document info
- View All
Overview
status
publication date
- January 1, 2020
published in
- Cardiology in the Young Journal
- Cardiology in the Young Journal